Jci_page_head_homepage_01 Jci_page_head_homepage_02
Matthew J. Flick, XinLi Du, David P. Witte, Markéta Jiroušková, Dmitry A. Soloviev, Steven J. Busuttil, Edward F. Plow, Jay L. Degen
Published in Volume 113, Issue 11
J Clin Invest. 2004; 113(11):1596–1606 doi:10.1172/JCI20741
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2

Characterization of Fibγ390–396A fibrinogen. (A) Western blot of fibrinogen in plasma from WT and mutant mice. (B) Coomassie blue–stained SDS polyacrylamide gel (reducing conditions) showing affinity-purified fibrinogen preparations from WT and Fibγ 390–396A mice. (C) Comparative analysis of thrombin-induced fibrin polymerization in plasma from WT and homozygous Fibγ 390–396A mice. (D) Analysis of fXIIIa-mediated fibrin cross-linking in reaction mixtures containing either purified WT or γ390–396A fibrinogen. The electrophoretic positions of Aα, Bβ, γ chains are indicated at left along with γ-γ dimer and α polymer cross-linking products.